A carregar...
Augmenting SRIs for OCD: Patient preference for risperidone does not limit effectiveness of exposure and ritual prevention
Patients with obsessive-compulsive disorder (OCD) often only partially respond to serotonin reuptake inhibitors (SRIs), the first-line pharmacotherapy for OCD. The American Psychiatric Association's Practice Guidelines suggest augmenting SRIs with either cognitive behavioral therapy consisting...
Na minha lista:
| Publicado no: | Psychother Psychosom |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031481/ https://ncbi.nlm.nih.gov/pubmed/27513584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000445356 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|